Norinchukin Bank, The Biogen Inc. Transaction History

Norinchukin Bank, The

$4.18 Billion
Q3 2024

A detailed history of Norinchukin Bank, The transactions in Biogen Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 7,321 shares of BIIB stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,321

Previous 6,298 16.24%

Holding current value

$1.09 Million

Previous $1.46 Million 2.81%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $193,418 - $242,246	1,023 Added 16.24%	7,321 $1.42 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $8,001 - $9,942	42 Added 0.67%	6,298 $1.46 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $26,502 - $33,463	-125 Reduced 1.96%	6,256 $1.35 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $205,673 - $247,576	-924 Reduced 12.65%	6,381 $1.65 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $1.85 Million - $2.09 Million	7,305 New	7,305 $1.88 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $954,291 - $1.1 Million	3,467 Added 30.11%	14,980 $4.27 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $74,402 - $84,778	290 Added 2.58%	11,513 $3.2 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $684,617 - $831,824	-2,712 Reduced 19.46%	11,223 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $269,256 - $371,280	1,383 Added 11.02%	13,935 $3.72 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $505,045 - $600,592	-2,693 Reduced 17.66%	12,552 $2.56 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $264,689 - $333,495	1,366 Added 9.84%	15,245 $3.21 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $234,668 - $301,582	-1,048 Reduced 7.02%	13,879 $3.33 Million
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $209,412 - $273,097	740 Added 5.22%	14,927 $4.22 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $6,734 - $10,782	26 Added 0.18%	14,187 $4.91 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $127,548 - $149,430	525 Added 3.85%	14,161 $3.96 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $107,025 - $161,100	-453 Reduced 3.22%	13,636 $3.34 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1,588 - $1,834	-6 Reduced 0.04%	14,089 $4 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $417,477 - $552,875	-1,614 Reduced 10.27%	14,095 $3.77 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $3.77 Million - $4.78 Million	-14,015 Reduced 47.15%	15,709 $4.97 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $626,730 - $865,991	-2,848 Reduced 8.74%	29,724 $8.82 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $205,915 - $230,954	-947 Reduced 2.83%	32,572 $7.58 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $3.15 Million - $3.47 Million	-14,353 Reduced 29.98%	33,519 $7.84 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $47,459 - $74,232	219 Added 0.46%	47,872 $11.3 Million
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $3.22 Million - $4.08 Million	11,578 Added 32.09%	47,653 $14.3 Million
Q3 2018 Nov 08, 2018	BUY	$293.51 - $383.83 $436,449 - $570,755	1,487 Added 4.3%	36,075 $12.7 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $347,909 - $414,635	1,351 Added 4.06%	34,588 $10 Million
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $1.46 Million - $2.07 Million	5,614 Added 20.32%	33,237 $9.1 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $354,708 - $397,300	1,153 Added 4.36%	27,623 $8.8 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $7.44 Million - $8.73 Million	26,470	26,470 $8.29 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Biogen Inc. Transaction History